Spain· ES:1191361003
SKYRIZI 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA
A medicinal product containing risankizumab, registered in Spain by Abbvie Deutschland Gmbh & Co. Kg.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- risankizumab
- Manufacturer
- Abbvie Deutschland Gmbh & Co. Kg
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Risankizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomSkyrizi 150mg/1ml solution for injection pre-filled pensAbbVie Ltd
- CzechiaSKYRIZIAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- SwedenSkyrizi 150 mg Injektionsvätska, lösning i förfylld injektionspennaAbbVie Deutschland GmbH & Co KG
- PolandSkyriziAbbVie Deutschland GmbH & Co. KG
- BelgiumSkyrizi 150 mgAbbVie Deutschland
- IcelandSkyriziAbbVie Deutschland GmbH & Co. KG
- NorwaySkyriziAbbVie Deutschland GmbH & Co
- United StatesSkyriziAbbVie Inc.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Skyrizi
- Iceland · Skyrizi
- Liechtenstein · Skyrizi
- Norway · Skyrizi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8c374dd7-9a85-4429-b0c4-8517e9101e9a GET /v1/drugs/8c374dd7-9a85-4429-b0c4-8517e9101e9a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1624897216000}",
"nregistro": "1191361003",
"substance": "risankizumab"
}See everything about risankizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.